Media contact: Savannah Koplon, skoplon@uab.edu
Paul Goepfert, M.D.
Marnix E. Heersink School of Medicine
Division of Infectious Diseases
Areas of expertise:
- Infectious Diseases
- Vaccines and vaccine research
- COVID-19
Paul Goepfert, M.D., is the director of the Alabama Vaccine Research Clinic. His laboratory concentrates on understanding the immune correlates of protection against HIV disease progression with a focus on cell medicated immune responses. In 2020, Goepfert was a high-ranking member on the Johnson and Johnson COVID-19 vaccine research trial in North America.
Media apperances:
- Why Americans shouldn't turn their noses up at Johnson & Johnson's vaccine, CNN
- FDA authorizes Johnson & Johnson’s single-shot coronavirus vaccine, adding to the nation’s arsenal against the pandemic, The Washington Post
- A future COVID-19 vaccine could be squirted up the nose. The nasal spray could stop transmission, especially in kids, Business Insider
- J&J vaccine could be a 'game changer.' Here's why a third option matters, NBC News